Padmashri Ponnaluri

Array ( [id] => 19953964 [patent_doc_number] => RE050451 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-06-10 [patent_title] => None [patent_app_type] => reissue [patent_app_number] => 15/229819 [patent_app_country] => US [patent_app_date] => 2016-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 0 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15229819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13262101 [patent_doc_number] => RE047150 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-12-04 [patent_title] => Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) [patent_app_type] => reissue [patent_app_number] => 15/208498 [patent_app_country] => US [patent_app_date] => 2016-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16737 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12443691 [patent_doc_number] => RE046873 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-05-29 [patent_title] => Multi-targeted RNAi therapeutics for scarless wound healing of skin [patent_app_type] => reissue [patent_app_number] => 15/166223 [patent_app_country] => US [patent_app_date] => 2016-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 25 [patent_no_of_words] => 20288 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15242483 [patent_doc_number] => RE047770 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-12-17 [patent_title] => Recombinant production of mixtures of antibodies [patent_app_type] => reissue [patent_app_number] => 15/158543 [patent_app_country] => US [patent_app_date] => 2016-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 31934 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15974287 [patent_doc_number] => RE048023 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2020-06-02 [patent_title] => Method for treating vascular-related disease [patent_app_type] => reissue [patent_app_number] => 15/158437 [patent_app_country] => US [patent_app_date] => 2016-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 43 [patent_no_of_words] => 9989 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13233659 [patent_doc_number] => RE047131 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-20 [patent_title] => Humanized immunoglobulin loci [patent_app_type] => reissue [patent_app_number] => 15/019852 [patent_app_country] => US [patent_app_date] => 2016-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 35 [patent_no_of_words] => 19128 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11928093 [patent_doc_number] => RE046585 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-10-24 [patent_title] => 'Optimized FC variants' [patent_app_type] => reissue [patent_app_number] => 14/993277 [patent_app_country] => US [patent_app_date] => 2016-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 33684 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14993277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11574058 [patent_doc_number] => RE046379 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-04-25 [patent_title] => 'Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer' [patent_app_type] => reissue [patent_app_number] => 14/964240 [patent_app_country] => US [patent_app_date] => 2015-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15539 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14964240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11581162 [patent_doc_number] => RE046382 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-05-02 [patent_title] => 'Methods and compositions for modulating peripheral immune function' [patent_app_type] => reissue [patent_app_number] => 14/874249 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 13088 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14874249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11928090 [patent_doc_number] => RE046583 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-10-24 [patent_title] => 'Vaccines comprising TB10.4' [patent_app_type] => reissue [patent_app_number] => 14/851672 [patent_app_country] => US [patent_app_date] => 2015-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 6790 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11655416 [patent_doc_number] => RE046425 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-06-06 [patent_title] => 'Pro-angiogenic peptides and uses thereof' [patent_app_type] => reissue [patent_app_number] => 14/734785 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 9544 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14734785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11879008 [patent_doc_number] => RE046534 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-09-05 [patent_title] => 'Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide' [patent_app_type] => reissue [patent_app_number] => 14/699845 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 40972 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699845 [rel_patent_id] =>[rel_patent_doc_number] =>)